MarketPulse
C

$CADL

3 articles found
1 positive
1 negative
1 neutral
BenzingaBenzinga··Rishabh Mishra

Equity Futures Pull Back on Softer-Than-Expected Fourth Quarter GDP Data

Stock futures fell Friday on weaker-than-expected Q4 GDP data. Mixed earnings reports and inflation figures kept investors focused on Fed policy ahead of March meeting.
SPYQQQGRALCPRTFIX+2earningsFederal Reserve
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Candel Therapeutics Raises $100M via Public Share Offering

Candel Therapeutics raises $100M via public share offering to fund commercialization of its prostate cancer gene therapy and ongoing lung cancer clinical trials.
CADLFDA approvalclinical trial
BenzingaBenzinga··Globe Newswire

Candel Therapeutics Plans $100M Stock Offering to Fund Cancer Treatment Pipeline

Candel Therapeutics plans $100M stock offering to fund cancer treatment pipeline development, particularly for prostate and lung cancer therapies.
CADLclinical trialpublic offering